Cleared Traditional

K222299 - Steripath Micro Blood Collection System

K222299 is an FDA 510(k) clearance for Steripath Micro Blood Collection System, manufactured by Magnolia Medical Technologies. The device is a Class 2 General Hospital device with product code JKA cleared through the Traditional 510(k) pathway after a 121-day FDA review.

K222299 · Magnolia Medical Technologies · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2022
Decision
121d
Days
Class 2
Risk

K222299 is an FDA 510(k) clearance for the Steripath Micro Blood Collection System. Classified as Tubes, Vials, Systems, Serum Separators, Blood Collection (product code JKA), Class II - Special Controls.

Submitted by Magnolia Medical Technologies (Seattle, US). The FDA issued a Cleared decision on November 30, 2022 after a review of 121 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 862.1675 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Magnolia Medical Technologies devices

FDA 510(k) Submission Details - K222299

510(k) Number K222299 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 01, 2022
Decision Date November 30, 2022
Days to Decision 121 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
8d faster than avg
Panel avg: 129d · This submission: 121d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JKA Device Classification - Class 2, Special Controls

Product Code JKA Tubes, Vials, Systems, Serum Separators, Blood Collection
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1675
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - JKA Tubes, Vials, Systems, Serum Separators, Blood Collection

All 119
Devices cleared under the same product code (JKA) and FDA review panel - the closest regulatory comparables to K222299.
BD Vacutainer® Luer-Lok™ Access Device, BD Vacutainer® Blood Transfer Device
K222478 · Becton, Dickinson and Company · Mar 2023
Kawasumi Multiple Sample Adapter with Pre-Attached Holder (MBCH)
K223810 · Sb-Kawasumi Laboratories, Inc. · Feb 2023
Safety Push Button Blood Collection Set
K222834 · Jiangsu Caina Medical Co.,Ltd · Jan 2023
Eclipse Blood Collection Set
K213690 · Eclipse Medcorp, LLC · Oct 2022
Safety Blood Collection Needle (Without Needle Holder)
K222141 · Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. · Oct 2022
Velano Vascular Blood Collection Adapter 
K201237 · Velano Vascular · Oct 2022